Strongbridge Biopharma Company Profile (NASDAQ:SBBP)

About Strongbridge Biopharma

Strongbridge Biopharma logoStrongbridge Biopharma plc, formerly Cortendo plc, is a development-stage biopharmaceutical company. The Company is engaged in advancing its product candidates through clinical development. The Company is focused on the development, in-licensing, acquisition and eventual commercialization of several complementary products and product candidates within franchises that target rare diseases. Its principal focus is to build its rare endocrine franchise, which includes product candidates for the treatment of endogenous Cushing's syndrome and acromegaly. Its product candidate, COR-003 (levoketoconazole), is a cortisol synthesis inhibitor, indicated for the treatment of endogenous Cushing's syndrome. It is conducting SONICS, a pivotal Phase III clinical trial for COR-003. Its product candidate, COR-005 (veldotide), is a multi-receptor targeted somatostatin analog (SSA) in Phase II clinical development for the treatment of acromegaly patients. Its product candidate also includes BP-2002.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SBBP
  • CUSIP:
Key Metrics:
  • Previous Close: $4.82
  • 50 Day Moving Average: $4.35
  • 200 Day Moving Average: $4.47
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.82
  • P/E Growth: 0.00
  • Market Cap: $102.00M
  • Outstanding Shares: 21,205,000
Additional Links:
Companies Related to Strongbridge Biopharma:

Analyst Ratings

Consensus Ratings for Strongbridge Biopharma (NASDAQ:SBBP) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.80 (228.48% upside)

Analysts' Ratings History for Strongbridge Biopharma (NASDAQ:SBBP)
Show:
DateFirmActionRatingPrice TargetDetails
6/22/2016HC WainwrightReiterated RatingBuyView Rating Details
2/3/2016Roth CapitalInitiated CoverageBuy$12.00View Rating Details
12/10/2015Janney Montgomery ScottInitiated CoverageBuy$19.00View Rating Details
12/7/2015Stifel NicolausReiterated RatingBuyView Rating Details
11/10/2015JMP SecuritiesInitiated CoverageOutperform$12.00View Rating Details
(Data available from 8/28/2014 forward)

Earnings

Earnings History for Strongbridge Biopharma (NASDAQ:SBBP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/17/2016        
5/17/2016Q1($0.63)($0.57)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Strongbridge Biopharma (NASDAQ:SBBP)
Current Year EPS Consensus Estimate: $-1.78 EPS
Next Year EPS Consensus Estimate: $-1.26 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.31)($0.31)($0.31)
Q2 20161($0.51)($0.51)($0.51)
Q3 20161($0.47)($0.47)($0.47)
Q4 20161($0.38)($0.38)($0.38)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Strongbridge Biopharma (NASDAQ:SBBP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Strongbridge Biopharma (NASDAQ:SBBP)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Strongbridge Biopharma (NASDAQ:SBBP)
DateHeadline
finance.yahoo.com logoStrongbridge Biopharma (SBBP) Jumps: Stock Moves Up 5.5% (NASDAQ:SBBP)
finance.yahoo.com - August 11 at 10:33 AM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:SBBP)
www.publicnow.com - July 6 at 7:51 AM
fxpips.com logoBig Moving Stocks Highlights Today – CCCL, RLOC, XNCR, CLWT, FUEL, ENDP, RNET (NASDAQ:SBBP)
www.fxpips.com - June 29 at 10:00 AM
publicnow.com logoStrongbridge Biopharma plc to Participate in the JMP Securities Life Sciences Conference and 3rd Annual ROTH Healthcare Day in London (NASDAQ:SBBP)
www.publicnow.com - June 14 at 7:59 AM
publicnow.com logoStrongbridge Biopharma plc Announces Executive Promotion and Leadership Transition (NASDAQ:SBBP)
www.publicnow.com - June 9 at 4:39 PM
capitalcube.com logoStrongbridge Biopharma Plc :SBBP-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 (NASDAQ:SBBP)
www.capitalcube.com - June 8 at 6:08 PM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation at Jefferies 2016 Healthcare Conference (NASDAQ:SBBP)
www.publicnow.com - June 2 at 4:15 PM
publicnow.com logoEY Announces Strongbridge Biopharma's President and CEO Matthew Pauls is Named an EY Entrepreneur Of The Year® 2016 Finalist in Greater Philadelphia (NASDAQ:SBBP)
www.publicnow.com - June 2 at 8:25 AM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation of COR-003 and COR-005 Data at the European Congress of Endocrinology (NASDAQ:SBBP)
www.publicnow.com - May 31 at 7:52 AM
publicnow.com logoStrongbridge Biopharma plc Reports First Quarter 2016 Financial Results (NASDAQ:SBBP)
www.publicnow.com - May 17 at 8:52 AM
sg.finance.yahoo.com logoStrongbridge Biopharma reports 1Q loss (NASDAQ:SBBP)
sg.finance.yahoo.com - May 17 at 8:42 AM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation at Bio€quity Europe 2016 (NASDAQ:SBBP)
www.publicnow.com - May 5 at 9:21 AM
finance.yahoo.com logoCoverage initiated on Strongbridge Biopharma by H.C. Wainwright (NASDAQ:SBBP)
finance.yahoo.com - April 25 at 7:09 AM
fxpips.com logoWhat’s Buzzing: Stock Gaps Up – LBTYB, SBBP, KOOL, LEU, CSTE, HLX, FOLD, HPJ, CHK, OBCI (NASDAQ:SBBP)
www.fxpips.com - April 13 at 10:55 AM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation at 15th Annual Needham Healthcare Conference (NASDAQ:SBBP)
www.publicnow.com - April 6 at 7:50 AM
fxpips.com logoThese Wall Street Stocks are Gapping Up today… (NASDAQ:SBBP)
www.fxpips.com - April 4 at 10:23 AM
thestreet.com logoStrongbridge Biopharma Plc Announces Presentation Of COR-003 Data At The Endocrine Society's 2016 Annual Conference (NASDAQ:SBBP)
www.thestreet.com - April 4 at 10:23 AM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation of COR-003 Data at the Endocrine Society’s 2016 Annual Conference (NASDAQ:SBBP)
www.publicnow.com - April 4 at 7:57 AM
finance.yahoo.com logoSTRONGBRIDGE BIOPHARMA PLC Financials (NASDAQ:SBBP)
finance.yahoo.com - March 30 at 1:04 PM
publicnow.com logoStrongbridge Biopharma plc Reports Full-Year 2015 Financial Results (NASDAQ:SBBP)
www.publicnow.com - March 24 at 7:56 AM
fxpips.com logoStocks Making Gaps Up today – FORK, STAF, SBBP, PNRG, SMLR, TGEN, DRIO (NASDAQ:SBBP)
www.fxpips.com - March 22 at 10:15 AM
fxpips.com logoActive Stocks Rising – SBBP, URRE, XNCR, THO, UNFI, OMER, LEU, SCTY, URBN, SUNE (NASDAQ:SBBP)
www.fxpips.com - March 10 at 9:52 AM
fxpips.com logoBiggest Moving Stocks, March 9 – URRE, OMER, OTEL, URBN, SBBP, SCTY, AMSC, EPIX, TERP (NASDAQ:SBBP)
www.fxpips.com - March 9 at 9:39 AM
bizjournals.com logoBucks biopharm firm returns one drug candidate, stops development of another (NASDAQ:SBBP)
www.bizjournals.com - March 7 at 10:55 AM
finance.yahoo.com logo7:33 am Strongbridge Biopharma provides update on corporate progress; co initiates the return of COR-004 to Antisense Therapeutics and will not invest further in the development of BP-2002 (NASDAQ:SBBP)
finance.yahoo.com - March 7 at 7:33 AM
finance.yahoo.com logoStrongbridge Biopharma plc Announces Presentations at Two Upcoming Investor Conferences (NASDAQ:SBBP)
finance.yahoo.com - February 25 at 7:30 AM
fxpips.com logoTraders Pick These Stocks Today – Strongbridge (SBBP), Aclaris (ACRS), Check-Cap (CHEK) (NASDAQ:SBBP)
www.fxpips.com - February 24 at 9:31 AM
fxpips.com logoManufacturing Sector’s Top Gainers and Losers, Feb. 22 (NASDAQ:SBBP)
www.fxpips.com - February 22 at 8:57 AM
finance.yahoo.com logoStrongbridge Biopharma Announces Annual General Meeting of Shareholders (NASDAQ:SBBP)
finance.yahoo.com - February 18 at 4:05 PM
finance.yahoo.com logoStrongbridge Biopharma plc Announces Participation at SunTrust Robinson Humphrey’s 2016 Orphan Drug Day (NASDAQ:SBBP)
finance.yahoo.com - February 18 at 7:30 AM
finance.yahoo.com logoStrongbridge Biopharma plc (SBBP) (NASDAQ:SBBP)
finance.yahoo.com - January 24 at 8:45 AM
noodls.com logoStrongbridge Biopharma plc Announces Presentation at Biotech Showcase 2016 (NASDAQ:SBBP)
www.noodls.com - December 16 at 7:56 AM
noodls.com logoStrongbridge Biopharma Announces Issuance of U.S. Patent for Investigational COR-003 (levoketoconazole) in Treatment of Endogenous Cushing's Syndrome (NASDAQ:SBBP)
www.noodls.com - December 7 at 7:52 AM
noodls.com logoStrongbridge Biopharma plc Announces Presentation at the 26th Annual Oppenheimer Healthcare Conference (NASDAQ:SBBP)
www.noodls.com - December 1 at 7:43 AM
finance.yahoo.com logoNew Information Reveals Opportunity in Volatility - Research on Strongbridge Biopharma, Pacific Mercantile Bancorp, Codexis and Exa Corp (NASDAQ:SBBP)
finance.yahoo.com - November 30 at 8:40 AM
noodls.com logoStrongbridge Biopharma plc Announces Presentation at Arctic Biotech Seminar (NASDAQ:SBBP)
www.noodls.com - November 23 at 7:45 AM
noodls.com logoStrongbridge Biopharma plc Provides Update on Corporate Progress (NASDAQ:SBBP)
www.noodls.com - November 18 at 8:55 AM
finance.yahoo.com logoStrongbridge Biopharma plc Announces Presentation at the Stifel 2015 Healthcare Conference (NASDAQ:SBBP)
finance.yahoo.com - November 4 at 7:30 AM
noodls.com logoATL1103: Data Presentation at the Society for Endocrinology BES 2015 Conference (NASDAQ:SBBP)
www.noodls.com - November 3 at 8:47 PM
noodls.com logoStrongbridge Biopharma plc Announces Data Presentation at the Society for Endocrinology BES 2015 Conference (NASDAQ:SBBP)
www.noodls.com - November 3 at 7:56 AM
finance.yahoo.com logoMast Therapeutics Announces Appointment Of Matthew Pauls To Board Of Directors (NASDAQ:SBBP)
finance.yahoo.com - November 2 at 8:00 AM
247wallst.com logoFerrari Leads IPO Calendar for Week of October 19 (NASDAQ:SBBP)
247wallst.com - October 18 at 9:29 AM

Social

Strongbridge Biopharma (NASDAQ:SBBP) Chart for Sunday, August, 28, 2016


Last Updated on 8/28/2016 by MarketBeat.com Staff